Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications

od Gentzler, Ryan D., Patel, Jyoti D.
Wydane 2014

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

od Khaddour, Karam, Gomez-Perez, Sandra L., Jain, Nikita, Patel, Jyoti D., Boumber, Yanis
Wydane w Front Oncol (2020)

Early Stage Lung Cancer Detection in Systemic Sclerosis Does Not Portend Survival Benefit: A Cross Sectional Study

od Katzen, Jeremy B., Raparia, Kirtee, Agrawal, Rishi, Patel, Jyoti D., Rademaker, Alfred, Varga, John, Dematte, Jane E.
Wydane w PLoS One (2015)

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center

od Choudhury, Noura J., Eghtesad, Mansooreh, Kadri, Sabah, Cursio, John, Ritterhouse, Lauren, Segal, Jeremy, Husain, Aliya, Patel, Jyoti D.
Wydane w Oncotarget (2019)

Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies

od Khaddour, Karam, Jonna, Sushma, Deneka, Alexander, Patel, Jyoti D., Abazeed, Mohamed E., Golemis, Erica, Borghaei, Hossein, Boumber, Yanis
Wydane w Cancers (Basel) (2021)

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials

od Langer, Corey J., Socinski, Mark A., Patel, Jyoti D., Sandler, Alan B., Schiller, Joan H., Leon, Larry, Hazard, Sebastien J., Ramalingam, Suresh S.
Wydane w Am J Clin Oncol (2016)

Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

od Johnson, Melissa L., Yu, Helena A., Hart, Eric M., Weitner, Bing Bing, Rademaker, Alfred W., Patel, Jyoti D., Kris, Mark G., Riely, Gregory J.
Wydane w J Clin Oncol (2015)

Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer

od Shah, Shalin, Wood, Kevin, Labadie, Brian, Won, Brian, Brisson, Ryan, Karrison, Theodore, Hensing, Thomas, Kozloff, Mark, Bao, Riyue, Patel, Jyoti D., Luke, Jason J.
Wydane w Oncotarget (2017)

CTNI-04. ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES

od Patel, Jyoti D, Farago, Anna F, Hong, David S, Lassen, Ulrik N, Leyvraz, Serge, Park, Keunchil, Sohal, Davendra P S, Solomon, Benjamin, Reeves, John A, Dima, Laura, Brega, Nicoletta, Drilon, Alexander
Wydane w Neuro Oncol (2020)

Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers

od Schink, Julian C., Trosman, Julia R., Weldon, Christine B., Siziopikou, Kalliopi P., Tsongalis, Gregory J., Rademaker, Alfred W., Patel, Jyoti D., Benson, Al B., Perez, Edith A., Gradishar, William J.
Wydane 2014

Acquired MET D1228V mutation and resistance to MET inhibition in lung cancer

od Bahcall, Magda, Sim, Taebo, Paweletz, Cloud P., Patel, Jyoti D., Alden, Ryan S., Kuang, Yanan, Sacher, Adrian G., Kim, Nam Doo, Lydon, Christine A., Awad, Mark M., Jaklitsch, Michael T., Sholl, Lynette M., Jänne, Pasi A., Oxnard, Geoffrey R.
Wydane w Cancer Discov (2016)

Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer

od Goldman, Jonathan W., Barve, Minal, Patel, Jyoti D., Wozniak, Antoinette, Dowlati, Afshin, Starodub, Alexander, Owonikoko, Taofeek K., Edenfield, William, Laurie, Scott A., Da Costa, Daniel, Lally, Satwant, Koch, Martina, Kosloski, Matthew P., Hoffman, David, Dy, Grace K.
Wydane w Clin Transl Sci (2020)

Phase II Study of Immunotherapy with Tecemotide and Bevacizumab after Chemoradiation in Patients with Unresectable Stage III Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC): A T...

od Patel, Jyoti D., Lee, Ju-Whei, Carbone, David P., Wagner, Henry, Shanker, Anil, de Aquino, Maria Teresa P., Horn, Leora, Johnson, Melissa L., Gerber, David E., Liu, Jane Jijun, Das, Millie S., Al-Nsour, Mohammed Ali, Dakhil, Christopher S. R., Ramalingam, Suresh, Schiller, Joan H.
Wydane w Clin Lung Cancer (2020)

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Be...

od Patel, Jyoti D., Socinski, Mark A., Garon, Edward B., Reynolds, Craig H., Spigel, David R., Olsen, Mark R., Hermann, Robert C., Jotte, Robert M., Beck, Thaddeus, Richards, Donald A., Guba, Susan C., Liu, Jingyi, Frimodt-Moller, Bente, John, William J., Obasaju, Coleman K., Pennella, Eduardo J., Bonomi, Philip, Govindan, Ramaswamy
Wydane w J Clin Oncol (2013)

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non–Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations From a Phase 1/2 Trial

od Riely, Gregory J., Neal, Joel W., Camidge, D. Ross, Spira, Alexander I., Piotrowska, Zofia, Costa, Daniel B., Tsao, Anne S., Patel, Jyoti D., Gadgeel, Shirish M., Bazhenova, Lyudmila, Zhu, Viola W., West, Howard L., Mekhail, Tarek, Gentzler, Ryan D., Nguyen, Danny, Vincent, Sylvie, Zhang, Steven, Lin, Jianchang, Bunn, Veronica, Jin, Shu, Li, Shuanglian, Jänne, Pasi A.
Wydane w Cancer Discov (2021)

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

od Luke, Jason J., Lemons, Jeffrey M., Karrison, Theodore G., Pitroda, Sean P., Melotek, James M., Zha, Yuanyuan, Al-Hallaq, Hania A., Arina, Ainhoa, Khodarev, Nikolai N., Janisch, Linda, Chang, Paul, Patel, Jyoti D., Fleming, Gini F., Moroney, John, Sharma, Manish R., White, Julia R., Ratain, Mark J., Gajewski, Thomas F., Weichselbaum, Ralph R., Chmura, Steven J.
Wydane w J Clin Oncol (2018)

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma

od Panou, Vasiliki, Gadiraju, Meghana, Wolin, Arthur, Weipert, Caroline M., Skarda, Emily, Husain, Aliya N., Patel, Jyoti D., Rose, Buerkley, Zhang, Shannon R., Weatherly, Madison, Nelakuditi, Viswateja, Knight Johnson, Amy, Helgeson, Maria, Fischer, David, Desai, Arpita, Sulai, Nanna, Ritterhouse, Lauren, Røe, Oluf D., Turaga, Kiran K., Huo, Dezheng, Segal, Jeremy, Kadri, Sabah, Li, Zejuan, Kindler, Hedy L., Churpek, Jane E.
Wydane w J Clin Oncol (2018)

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

od Wakelee, Heather A., Dahlberg, Suzanne E., Keller, Steven M., Tester, William J., Gandara, David R., Graziano, Stephen L., Adjei, Alex, Leighl, Natasha B., Aisner, Seena C., Rothman, Jan M., Patel, Jyoti D., Sborov, Mark D., McDermott, Sean R., Perez-Soler, Roman, Traynor, Anne M., Butts, Charles, Evans, Tracey, Shafqat, Atif, Chapman, Andrew E., Kasbari, Samer S., Horn, Leora, Ramalingam, Suresh S., Schiller, Joan
Wydane w Lancet Oncol (2017)

Small Cell Lung Cancer: Clinical Practice Guidelines in Oncology

od Kalemkerian, Gregory P., Akerley, Wallace, Bogner, Paul, Borghaei, Hossein, Chow, Laura QM, Downey, Robert J., Gandhi, Leena, Ganti, Apar Kishor P., Govindan, Ramaswamy, Grecula, John C., Hayman, James, Heist, Rebecca Suk, Horn, Leora, Jahan, Thierry, Koczywas, Marianna, Loo, Billy W., Merritt, Robert E., Moran, Cesar A., Niell, Harvey B., O’Malley, Janis, Patel, Jyoti D., Ready, Neal, Rudin, Charles M., Williams, Charles C., Gregory, Kristina, Hughes, Miranda
Wydane 2013

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)

od Peters, Solange, Gettinger, Scott, Johnson, Melissa L., Jänne, Pasi A., Garassino, Marina C., Christoph, Daniel, Toh, Chee Keong, Rizvi, Naiyer A., Chaft, Jamie E., Carcereny Costa, Enric, Patel, Jyoti D., Chow, Laura Q.M., Koczywas, Marianna, Ho, Cheryl, Früh, Martin, van den Heuvel, Michel, Rothenstein, Jeffrey, Reck, Martin, Paz-Ares, Luis, Shepherd, Frances A., Kurata, Takayasu, Li, Zhengrong, Qiu, Jiaheng, Kowanetz, Marcin, Mocci, Simonetta, Shankar, Geetha, Sandler, Alan, Felip, Enriqueta
Wydane w J Clin Oncol (2017)